APA (7th ed.) Citation

Vancheri, C., Kreuter, M., Richeldi, L., Ryerson, C. J., Valeyre, D., Grutters, J. C., . . . Wuyts, W. A. (2018). Nintedanib with add-on pirfenidone in idiopathic pulmonary fibrosis: Results of the INJOURNEY Trial. American journal of respiratory and critical care medicine, 197(3), . https://doi.org/10.1164/rccm.201706-1301OC

Chicago Style (17th ed.) Citation

Vancheri, Carlo, et al. "Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis: Results of the INJOURNEY Trial." American Journal of Respiratory and Critical Care Medicine 197, no. 3 (2018). https://doi.org/10.1164/rccm.201706-1301OC.

MLA (9th ed.) Citation

Vancheri, Carlo, et al. "Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis: Results of the INJOURNEY Trial." American Journal of Respiratory and Critical Care Medicine, vol. 197, no. 3, 2018, https://doi.org/10.1164/rccm.201706-1301OC.